Oncology status update: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) No edit summary |
||
Line 17: | Line 17: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Non-Hodgkin lymphoma (LP) | | style="padding: 5px 5px; background: #F5F5F5;" |Non-Hodgkin lymphoma (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" |needs hyperlinking | | style="padding: 5px 5px; background: #F5F5F5;" |needs hyperlinking | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 25: | Line 25: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Primary mediastinal large B-cell | | style="padding: 5px 5px; background: #F5F5F5;" |Primary mediastinal large B-cell | ||
| style="padding: 5px 5px; background: #F5F5F5;" |from Echocardiography till end need tollbar, references,.. | | style="padding: 5px 5px; background: #F5F5F5;" |from Echocardiography till end need tollbar, references,.. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 33: | Line 33: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |B cell prolymphocytic leukemia | | style="padding: 5px 5px; background: #F5F5F5;" |B cell prolymphocytic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" |needs refernces | | style="padding: 5px 5px; background: #F5F5F5;" |needs refernces | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 42: | Line 42: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hepatosplenic T cell lymphoma | | style="padding: 5px 5px; background: #F5F5F5;" |Hepatosplenic T cell lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" |some sections haven't been written. | | style="padding: 5px 5px; background: #F5F5F5;" |some sections haven't been written. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 50: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Warthin's tumor | | style="padding: 5px 5px; background: #F5F5F5;" |Warthin's tumor | ||
| style="padding: 5px 5px; background: #F5F5F5;" |needs some content and references | | style="padding: 5px 5px; background: #F5F5F5;" |needs some content and references | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 57: | Line 57: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Pleomorphic adenoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |needs DDx table | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 66: | Line 66: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Salivary gland tumor (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |needs DDx table, Historical perspective, some pages need hyperlinking | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 75: | Line 75: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |T cell prolymphocytic leukemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |needs DDx table, some parts haven't been written. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 84: | Line 84: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Enteropathy-associated T-cell lymphoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |needs DDx table, it's not according to our template. | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 93: | Line 93: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Villous adenoma (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |change the toolbar like a single page | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 683: | Line 683: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Mahshid | ||
|- | |- | ||
|- | |- | ||
Line 701: | Line 701: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Farima | ||
|- | |- | ||
|- | |- | ||
Line 710: | Line 710: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sadaf | ||
|- | |- | ||
|- | |- | ||
Line 728: | Line 728: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Datta | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 737: | Line 736: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
|- | |- | ||
Line 755: | Line 755: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Amandeep | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 764: | Line 763: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
|- | |- | ||
Line 800: | Line 800: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anmol | ||
|- | |- | ||
|- | |- | ||
Line 809: | Line 809: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hasan | ||
|- | |- | ||
|- | |- | ||
Line 818: | Line 818: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hasan | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 827: | Line 826: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
|- | |- | ||
Line 836: | Line 836: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Khurram | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 845: | Line 844: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
|- | |- | ||
Line 1,094: | Line 1,094: | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 1,109: | Line 1,109: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Ahmed | ||
|- | |- | ||
|- | |- | ||
Line 1,118: | Line 1,118: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sabawoon | ||
|- | |- | ||
|- | |- | ||
Line 1,127: | Line 1,127: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Mahshid | ||
|- | |- | ||
|- | |- | ||
Line 1,136: | Line 1,136: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hasan | ||
|- | |- | ||
|- | |- | ||
Line 1,145: | Line 1,145: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anmol | ||
|- | |- | ||
|- | |- | ||
Line 1,154: | Line 1,154: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Ahmed | ||
|- | |- | ||
|- | |- | ||
Line 1,163: | Line 1,163: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Hasan | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Cervical polyp (SP) | | style="padding: 5px 5px; background: #F5F5F5;" |Cervical polyp (SP) |
Revision as of 16:08, 7 July 2020
System leader: Farima Kahe, M.D.
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Oncology | Non-Hodgkin lymphoma (LP) | needs hyperlinking | |||||
Primary mediastinal large B-cell | from Echocardiography till end need tollbar, references,.. | ||||||
B cell prolymphocytic leukemia | needs refernces | ||||||
Hepatosplenic T cell lymphoma | some sections haven't been written. | ||||||
Warthin's tumor | needs some content and references | ||||||
Pleomorphic adenoma | needs DDx table | ||||||
Salivary gland tumor (LP) | needs DDx table, Historical perspective, some pages need hyperlinking | ||||||
T cell prolymphocytic leukemia | needs DDx table, some parts haven't been written. | ||||||
Enteropathy-associated T-cell lymphoma | needs DDx table, it's not according to our template. | ||||||
Villous adenoma (SP) | change the toolbar like a single page | ||||||
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Oncology | |||||||
Completed chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Oncology | Acute lymphoblastic leukemia | Hassan | |||||
Acute myeloid leukemia | Aditya | ||||||
Acute promyelocytic leukemia | Aditya | ||||||
Adult T-cell leukemia | Sadaf | ||||||
Anaplastic large cell lymphoma | Sargun | ||||||
Burkitt's lymphoma | Hassan | ||||||
Chronic lymphocytic leukemia | Sogand | ||||||
Chronic myelogenous leukemia | Mahshid | ||||||
Chronic neutrophilic leukemia | Sadaf | ||||||
Diffuse large B cell lymphoma | Elsaiey | ||||||
Follicular lymphoma | Younes | ||||||
Hairy cell leukemia | Elsaiey | ||||||
Hodgkin's lymphoma | Hasan | ||||||
Leukemia (LP) | Anmol | ||||||
Leukocytosis (SP) | Mehrian | ||||||
Hemophilia | Sogand | ||||||
Lymphadenopathy | Mehrian | ||||||
Lymphangioma | Mahshid | ||||||
Lymphangiomyomatosis (SP) | Amandeep | ||||||
Lymphangiosarcoma (SP) | Hassan | ||||||
Lymphoma (LP) | Anmol | ||||||
Lymphomatoid granulomatosis | Anmol | ||||||
Mast cell leukemia | Farima | ||||||
Mast cell tumor | Elsaiey | ||||||
Multiple myeloma | Sadaf | ||||||
Myelodysplastic syndrome | Elsaiey | ||||||
Myelofibrosis | Sadaf | ||||||
Nodal marginal zone lymphoma | Mahshid | ||||||
Polycythemia vera | Farima | ||||||
Primary effusion lymphoma | Sadaf | ||||||
Prolymphocytic leukemia (LP) | Datta | ||||||
Splenic marginal zone lymphoma | Amandeep | ||||||
T-cell lymphoma (LP) | Anmol | ||||||
Waldenström's macroglobulinemia | Sara | ||||||
Hypopharyngeal cancer | Anmol | ||||||
Laryngeal cancer | Hasan | ||||||
Oral cancer | Hasan | ||||||
Tongue cancer | Khurram | ||||||
Mucoepidermoid carcinoma | Sargun | ||||||
Nasopharyngeal angiofibroma (SP) | Mehrian | ||||||
Nasopharyngeal carcinoma | Farima | ||||||
Appendix cancer | Anmol | ||||||
Blue rubber bleb nevus syndrome | Farima | ||||||
Carcinoid syndrome | Ahmed Y. | ||||||
Cholangiocarcinoma | Mehrian | ||||||
Colorectal cancer | Khurram | ||||||
Desmoplastic small round cell tumor (SP) | Mahshid | ||||||
Esophageal cancer | Mehrian | ||||||
Familial adenomatous polyposis | Usama | ||||||
Fibrolamellar hepatocellular carcinoma (SP) | Mehrian | ||||||
Gallbladder cancer | Farima | ||||||
Gastrointestinal stromal tumor | Sogand | ||||||
Hepatoblastoma | Aditya | ||||||
Hepatocellular adenoma | Sabawoon | ||||||
Hepatocellular carcinoma | Ahmed | ||||||
Hereditary nonpolyposis colorectal cancer | Sabawoon | ||||||
Liver mass | Khurram | ||||||
MALT lymphoma | Ahmed | ||||||
Mantle cell lymphoma | Farima | ||||||
Pancreatic cancer | Hassan | ||||||
Pancreatic islet cell carcinoma | Farima | ||||||
Peutz-Jeghers syndrome | Anmol | ||||||
Pseudomyxoma peritonei (SP) | Datta | ||||||
Small intestine cancer | Anmol | ||||||
Stomach cancer | Mahshid | ||||||
VIPoma | Ahmed | ||||||
Zollinger-Ellison syndrome | Sabawoon | ||||||
Peritoneal carcinomatosis (SP) | Mahshid | ||||||
Breast cancer | Hasan | ||||||
Breast lumps | Anmol | ||||||
Cervical cancer | Ahmed | ||||||
Cervical intraepithelial neoplasia (SP) | Hasan | ||||||
Cervical polyp (SP) | |||||||
Endodermal sinus tumor | |||||||
Endometrial cancer | |||||||
Endometrial hyperplasia | |||||||
Endometrial intraepithelial neoplasia (SP) | |||||||
Gestational trophoblastic neoplasia | |||||||
Ovarian cancer (LP) | |||||||
Epithelial ovarian tumors | |||||||
Ovarian germ cell tumor | |||||||
Sexcord/ stromal ovarian tumor | |||||||
Krukenberg tumor (SP) | |||||||
Meigs syndrome (SP) | |||||||
Ovarian Sarcoma | |||||||
Leiomyoma (SP) | |||||||
Leiomyosarcoma | |||||||
Mixed Mullerian tumor (SP) | |||||||
Mucinous cystadenocarcinoma | |||||||
Primary peritoneal cancer (SP) | |||||||
Vaginal cancer | |||||||
Vulvar cancer | |||||||
Adrenolipoma (SP) | |||||||
Extramammary Paget's disease | |||||||
Fibroadenoma | |||||||
Paget's disease of the breast | |||||||
Atrial myxoma | |||||||
Germinoma | |||||||
Gonadoblastoma (SP) | |||||||
Mediastinal mass | |||||||
Sarcoma botryoides (SP) | |||||||
Prostate cancer | |||||||
Scrotal mass | |||||||
Seminoma | |||||||
Testicular cancer | |||||||
Erythroplasia of Queyrat | |||||||
Carcinoma of the penis | |||||||
Acoustic neuroma | |||||||
Atypical teratoid rhabdoid tumor (SP) | |||||||
Dysembryoplastic neuroepithelial tumor (SP) | |||||||
Esthesioneuroblastoma (SP) | |||||||
Glioma (LP) | |||||||
Ependymoma | |||||||
Subependymoma (SP) | |||||||
Ganglioglioma | |||||||
Oligodendroglioma | |||||||
Brain Stem gliomas | |||||||
Optic nerve glioma | |||||||
Astrocytoma | |||||||
Fibrillary astrocytoma (SP) | |||||||
Gemistocytic astrocytoma (SP) | |||||||
Familial mediterranean fever | |||||||
Protoplasmic astrocytoma (SP) | |||||||
Oligoastrocytoma | |||||||
Glioblastoma multiforme | |||||||
Pleomorphic xanthoastrocytoma (SP) | |||||||
Subependymal giant cell astrocytoma | |||||||
Gliomatosis cerebri | |||||||
Primary central nervous system lymphoma | |||||||
Primitive neuroectodermal tumor (SP) | |||||||
Pineoblastoma (SP) | |||||||
Ependymoblastoma (SP) | |||||||
Medulloblastoma |
|||||||
Pituitary tumor (LP) | |||||||
Pituitary adenoma | |||||||
Pituitary carcinoma (SP) | |||||||
Craniopharyngioma | |||||||
Malignant peripheral nerve sheath tumor | |||||||
Medulloepithelioma (SP) | |||||||
Meningioma | |||||||
Neoplastic meningitis | |||||||
Neuroblastoma | |||||||
Neurofibroma (SP) | |||||||
Oncocytoma | |||||||
Paraneoplastic cerebellar degeneration (SP) | |||||||
Pineal gland tumor (LP) | |||||||
Pineal choriocarcinoma (SP) | |||||||
Pineal embryonal carcinoma (SP) | |||||||
Pineal germinoma (SP) | |||||||
Pineal parenchymal tumors (SP) | |||||||
Pineal teratoma (SP) | |||||||
Pineal yolk sac tumor (SP) | |||||||
Pineocytoma (SP) |
|
||||||
Post-chemotherapy cognitive impairment | |||||||
Schwannoma (LP) | |||||||
Vestibular tumor (SP) | |||||||
Neuroma (LP) | |||||||
Eye neoplasm (LP) | |||||||
Intraocular lymphoma | |||||||
Lisch nodule (SP) | |||||||
Retinoblastoma | |||||||
Uveal melanoma | |||||||
Rhabdomyoma | |||||||
Rhabdomyosarcoma |
|
||||||
Sarcoma (SP) | |||||||
Surface epithelial-stromal tumor (SP) | |||||||
Teratoma | |||||||
Lipoma | |||||||
Liposarcoma | |||||||
Myxoma | |||||||
PEComa (SP) | |||||||
Elastofibroma (SP)
Epithelioid sarcoma Fibroma Glomus tumor |